Proton Magnetic Resonance Spectroscopy an in Vivo Method of Estimating Hippocampal Neuronal Depletion in Schizophrenia

Psychological Medicine

Volumn 25, Issue 6, 1995, Pages 1201-1209

  Maier, M ^a   Ron, M A ^a   Barker, G J ^a   Tofts, P S ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINE; CREATINE; N ACETYLASPARTIC ACID;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOARCHITECTURE; HIPPOCAMPUS; HUMAN; NERVE CELL DEGENERATION; PROTON NUCLEAR MAGNETIC RESONANCE; SCHIZOPHRENIA; TEMPORAL LOBE;

ADULT; CHOLINE DEFICIENCY; CREATINE; FEMALE; FUNCTIONAL LATERALITY; HIPPOCAMPUS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NERVE DEGENERATION; SCHIZOPHRENIA;

EID: 0028868860     PISSN: 00332917     EISSN: 14698978     Source Type: Journal    
DOI: 10.1017/S0033291700033171     Document Type: Article

References (57)

1. Altshuler, L. L. (1987). Hippocampal pyramidal cell orientation in schizophrenia. Archives of General Psychiatry 44, 1094–1098.
2. Arnold, D. L. (1992). Reversible reduction of NAA after acute central nervous system damage. Society of Magnetic Resonance in Medicine (Book of Abstracts) 1, 643.
3. Arnold, D. L., Mathews, P. M., Francis, G. & Antel, J. (1990). Proton magnetic resonance spectroscopy of human brain in vivo in the evaluation of multiple sclerosis: assessment of the load of the disease. Magnetic Resonance in Medicine 14, 154–159.
4. Austin, S. J., Connelly, A., Gadian, D. G., Benton, J. S. & Brett, E. M. (1991). Localized ‘[H]NMR spectroscopy in Canavan's Disease: a report of two cases. Magnetic Resonance in Medicine 19, 439–445.
5. Birken, D. L. & Oldendorf, W. H. (1989). N-acetyl-l-aspartic add: a literature review of a compound prominent in [H]-NMR spectroscopic studies of brain. Neuroscience and Behavioural Reviews 13, 23–31.
6. Bogerts, B., Ashtari, M., DeGreef, G., Alvir, J.-M.S., Bilder, R. M. & Lieberman, J. A. (1990). Reduced temporal limbic structure volumes on magnetic resonance images in first episode schizophrenia. Psychiatry Research 35, 1–13.
7. Breiter, S. N., Arroyo, S., Mathews, V. P., Lesser, R. P., Bryan, R. N. & Barker, P. B. (1994). Proton MR spectroscopy in patients with seizure disorders. American Journal of Neuroradiology 15, 373–384.
8. Brenner, R. E., Beech, J. S., Williams, S. C. R., Bell, J. D. & McDonald, W. I. (1993). Reversibility of the reduction of NAA in diabetic ketoacidosis. Society of Magnetic Resonance in Medicine (Book of Abstracts) 3, 1559.
9. Brown, R., Colter, N., Corsellis, J. A. N., Crow, T. J., Frith, C. D., Jagoe, R., Johnstone, E. C. & Marsh, L. (1986). Postmortem evidence of structural brain changes in schizophrenia. Archives of General Psychiatry 43, 36–42.
10. Bruhn, H., Frahm, J., Gyngell, M. L., Merboldt, K. D., Haenicke, W. & Sauter, R. (1989). Cerebral metabolism in man after acute stroke: new observations using localized proton NMR spectroscopy. Magnetic Resonance in Medicine 9, 126–131.
11. Bruhn, H., Weber, T., Thorwirth, V. & Frahm, J. (1991). In vivo monitoring of neuronal loss in Creutzfeldt-Jakob disease by proton magnetic resonance spectroscopy. Lancet 337, 1610–1611.
12. Buckley, P., Moore, C., Larkin, C., Mulvany, F., Redmond, O., Stack, J. P., Ennis, J. T. & Waddington, J. L. (1993). ‘[H] magnetic resonance spectroscopy of frontal and temporal lobe metabolism in schizophrenia. Schizophrenia Bulletin (Special Issue) p. 194.
13. Calabrese, G., Deicken, R. F., Feine, G., Merrin, E. L., Schoenfeld, F. & Weiner, M. W. (1992). 31-Phosphorous magnetic resonance spectroscopy of the temporal lobes in schizophrenia. Biological Psychiatry 32, 26–32.
14. Chi, J. G., Dooling, E. C. & Gilles, F. H. (1977). Gyral development of the human brain. Anna Is of Neurology 1, 86–93.
15. Chong, W. K., Sweeney, B., Wilkinson, I. D., Paley, M., Hall-Craggs, M. A., Kendall, B. E., Shepard, J. K., Beecham, M., Miller, R. F., Weller, I. V. D., Newman, S. P. & Harrison, M. J. (1993). Proton spectroscopy of the brain in HIV infection: correlation with clinical immunologic and MR imaging findings. Radiology 188, 119–124.
16. Conrad, A. J., Abebe, T., Austin, R., Forsythe, S. & Scheibel, A. B. (1991). Hippocampal pyramidal cell disarray in schizophrenia as a bilateral phenomenon. Archives of General Psychiatry 48,.413-417
17. Davie, C. A., Hawkins, C. P., Barker, G. J., Brennan, A., Tofts, P.S., Miller, D. H. & McDonald, W. I. (1994). Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions. Brain 117, 49–58.
18. De Stefano, N., Francis, G., Antel, J. P. & Arnold, D. L. (1993). Reversible decreases of NAA in the brain of patients with replacing remitting multiple sclerosis. Society of Magnetic Resonance in Medicine (Book of Abstracts) 1, 280.
19. DeCarli, C., Murphy, D. G. M., Gillette, J. A., Haxby, J. V., Teichberg, D., Schapiro, M. B. & Horwitz, B. (1994). Lack of age-related differences in temporal lobe volume of very healthy adults. American Journal of Neuroradiology 15, 689–696.
20. Demisch, L., Gerbaldo, H., Heinz, K. & Kirsten, R. (1987). Transmembranal signalling in schizophrenic and affective disorders: studies on arachidonic acid and phospholipids. Schizophrenia Research 22, 275–282.
21. Espanol, M. T., Yang, G. Y., Shimizu, H., Xu, Y., Chang, L. H., Weinstein, P., Litt, L. & James, T. L. (1992). Does NAA predict outcome of transient global cerebral ischaemia in rat brain? Society of Magnetic Resonance in Medicine (Book of Abstracts) 2, 2148.
22. Falkai, P. & Bogerts, B. (1986). Cell loss in the hippocampus of schizophrenics. European Archives of Psychiatry and Neurological Sciences 236, 154–161.
23. Fisher, M., Sotak, C. H., Minematsu, K. & Li, L. (1992). New magnetic resonance techniques for evaluating cerebrovascular disease. Annals of Neurology 32, 115–122.
24. Frahm, J., Bruhn, H., Glyngell, M. L., Merboldt, K. D., Hanicke, W. & Sauter, R.(1989a). Localized high-resolution proton NMR spectroscopy using stimulated echoes: initial applications to human brain in vivo. Magnetic Resonance in Medicine 9, 79–93.
25. Frahm, J., Bruhn, H., Gyngell, M. L., Merboldt, K. D., Haenicke, W. & Sauter, R. (1989b). Localized proton NMR spectroscopy in different regions of the human brainin vivo. Relaxation times and concentrations of cerebral metabolites. Magnetic Resonance in Medicine 11, 47–63.
26. Frahm, J., Michaelis, T., Merboldt, K. D., Bruhn, H. Gyngell, M. L. & Hanicke, W. (1990). Improvements in localized proton NMR spectroscopy of human brain: water suppression, short echo times, and 1 ml resolution. Journal of Magnetic Resonance 90, 464–473.
27. Gattaz, W. F., Kolisch, M., Thuren, T., Virtanen, J. A. & Kinnunen, P. K. J. (1987). Increased plasma phospholipase A2 activity in schizophrenic patients: reduction after neuroleptic therapy. Biological Psychiatry 22, 421–426.
28. Gill, S. S., Thomas, D. G. T., Van Bruggen, N., Gadian, D. G., Peden, C. J., Bell, J. D., Cox, J., Menon, D. K., Lles, R. A., Bryant, D. J. & Coutts, G. A. (1990). Proton MR spectroscopy of intracranial tumours: in vivo and in vitro studies. Journal of Computer Assisted Tomography 14, 497–504.
29. Graham, S. H., Meyerhoff, D. J., Bayne, L., Sharp, F. R. & Weiner, M. W. (1994). Magnetic resonance spectroscopy of N-acetyl aspartate in hypoxic-ischaemic encephalopathy. Annals of Neurology 35, 490–494.
30. Grodd, W., Kraegeloh-Mann, I., Peterson, D., Trefz, F. K. & Harzer, K. (1990). In vivo assessment of N-acetyl aspartate in brain in spongy degeneration (Canavan's disease) by proton spectroscopy. Lancet 336, 437–438.
31. Harvey, I., Ron, M. A., Du Boulay, G., Wicks, D., Lewis, S. W. & Murray, R. M. (1993). Reduction of cortical volumein schizophrenia on magnetic resonance imaging. Psychological Medicine 23, 591–604.
32. Hechers, S., Heinsen, H., Geiger, B. & Beckmann, H. (1991). Hippocampal Neuronal Number in Schizophrenia. Archives of General Psychiatry 48, 1002–1008.
33. Hitzemann, R., Hirschowitz, D. & Garver, D. (1984). Membrane abnormalities in the psychoses and affective disorders. Journal of Psychiatric Research 18, 319–326.
34. Inglis, B. A., Brenner, R. E., Munro, P. M. G., Williams, S. C. R., McDonald, W. I. & Sales, K. D. (1992). Measurement of proton NMR relaxation times for NAA, Cr and Cho in acute EAE. Society of Magnetic Resonance in Medicine (Book of Abstracts) 2, 2162.
35. Kaiya, H., Takeuchi, K., Namba, M., Imcu, A., Nakashima, S. & Nozawa, Y. (1984). Abnormal phosphatidylinositol-cycle of platelet membrane in schizophrenia: A preliminary study. Folia Psychiatrica et Neurologica Japonica 38, 437–444.
36. Koller, K. J., Zaczek, R, & Coyle, J. T. (1984). N-acetyl-aspartyl- glutamate: regional levels in rat brain and the effects of brain lesions as determined by a new HPLC method. Journal of Neurochemistry 43, 1136–1142.
37. Marsh, L., Suddath, R. L., Higgins, N. & Weinberger, D. R. (1994). Medial temporal lobe structures in schizophrenia: relationship of size to duration of illness. Schizophrenia Research 11, 225–238.
38. Michaelis, T., Merboldt, K. D., Bruhn, H., Haenicke, W. & Frahm, J. (1993). Absolute concentrations of metabolites in the adult human brain in vivo: quantification of localized proton MR spectra. Radiology 187, 219–227.
39. Miller, B. L. (1991). A review of chemical issues in i[H]NMR spectroscopy: N-acetyl-L-aspartate, creatine and choline. NMR in Biomedicine 4, 47–52.
40. Miller, D. H., Austin, S. J., Connelly, A., Youl, B. D., Gadian, D. G. & McDonald, W. I. (1991). Proton magnetic resonance spectroscopy of an acute and chronic lesion in multiple sclerosis. Lancet 337, 58–59.
41. Moore, C. M., Redmond, O. M., Buckley, P., Larkin, C., Stack, J. P., Waddington, J. & Ennis, J. T. (1992). In vivo proton NMR spectroscopy (STEAM) in patients with schizophrenia. Society of Magnetic Resonance in Medicine (Book of Abstracts) 1, 1933.
42. Nasrallah, H. A., Skinner, T. E., Schmalbrock, P. & Robitaille, P. M. (1992). In vivo proton magnetic resonance spectroscopy (MRS) of the hippocampus/amygdala region in schizophrenia. Schizophrenia Bulletin (Special Issue) p. 150.
43. Okumura, N. Otsuki, S. & Nasu, H. (1959). The influence of insulin hypoglycaemic coma, repeated electroshocks, and chlorpromazine or beta-phenylisopropylmethylamine administration on the free amino acids in the brain. Journal of Biochemistry 46, 247–252.
44. Pangerl, A. M., Steudle, A., Jaroni, H. W., Rufer, R. & Gattaz, W. F. (1991). Increased platelet membrane lysophosphatidylcholine in schizophrenia. Biological Psychiatry 8, 837–840.
45. Pettegrew, J. W., Withers, G., Panchalingam, K. & Post, J. F. M. (1987). 31 [P]Nuclear magnetic resonance (NMR) spectroscopy of brain in aging and Altheimer's disease. Journal of Neural Transmission 24, (Supplement), 261–268.
46. Pettegrew, J. W., Moossy, J., Withers, G., McKeag, D. & Panchalingam, K. (1988). 31[P]Nuclear magnetic resonance study of the brain in Alzheimer's disease. Journal of Neuropathology and Experimental Neurology 47, 235–248.
47. Roberts, G. W. (1991). Schizophrenia: a neuropathological perspective. British Journal of Psychiatry 158, 8–17.
48. Scheibel, A. B. & Conrad, A. S. (1993). Hippocampal dysgenesis in mutant mouse and schizophrenic man: is there a relationship? Schizophrenia Bulletin 19, 21–33.
49. Sharma, R., Venkatasubramanian, P. N., Barany, M. & Davis, J. M. (1992). Proton magnetic resonance spectroscopy of the brain in schizophrenic and affective patients. Schizophrenia Research 8, 43–49.
50. Steudle, A., Maras, A. & Gattaz, W. F. (1994). Platelet membrane phospholipids in schizophrenia. Schizophrenia Research 11, 123.
51. Stevens, J. D. (1972). The distribution of phospholipid fractions in the red cell membranes of schizophrenics. Schizophrenia Bulletin 6, 60–61.
52. Suddath, R. L., Casanova, M. F., Goldberg, T. E., Daniel, D. G., Kelsoe, J. R. & Weinberger, D. R. (1989). Temporal lobe pathology in schizophrenia: a quantitative magnetic resonance imagingstudy. American Journal of Psychiatry 146, 464–472.
53. Tews, J. K., Carter, S. H., Roa, P. D. & Stone, W. E. (1963). Free amino acids and related compounds in dog brain: post-mortem and anoxic changes, effects of ammonium chloride infusion, and levels during seizures induced by picrotoxin and by pentylenetetrazol. Journal of Neurochemistry 10, 641–653.
54. Toft, P. B., Christiansen, P., Pryds, O., Lou, H. C. & Henriksen, O. (1994). T1, T2, and concentrations of brain metabolites in neonates and adolescents estimated with H-l MR spectroscopy. Journal of Magnetic Resonance Imaging 4, 1–5.
55. Waddington, J. L. (1993). Schizophrenia: Developmental neuroscience and pathobiology. Lancet 341, 531–536.
56. Yurgelun-Todd, D. A., Renshaw, P. F., Waternaux, S. A., Gruber, S. A. & Cohen, B. M. (1993). ‘H spectroscopy of the temporal lobes in schizophrenic and bipolar patients. Society of Magnetic Resonance in Medicine (Book of Abstracts) 3, 1539.
57. Zipursky, R. B., Lim, K. O., Sullivan, E. V., Brown, B. W. & Pfefferbaum, A. (1992). Widespread cerebral grey matter volume deficits in schizophrenia. Archives of General Psychiatry 49, 195–205.